Lebrikizumab Treatment Improves Lichenification and Other Clinical Signs of Atopic Dermatitis in Adults and Adolescents with Moderate-to-Severe AD and Skin of Color. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s625, 2025. DOI: 10.25251/0262jz84. Disponível em: https://skin.dermsquared.com/skin/article/view/3861. Acesso em: 1 may. 2026.